✕
Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
 简体中文 (Simplified Chinese) | 繁體中文 (Traditional Chinese)
BEHIND THE SCIENCE
Focused on providing actionable insights to clinicians.

MediBeacon’s use of proprietary fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable measurement of organ function.

The Company’s Transdermal GFR Measurement System (TGFR) is designed to be a direct measure of Glomerular Filtration Rate (GFR) at the point of care. This system employs a fluorescent tracer agent which has been engineered to be excreted exclusively by the kidneys. Noninvasive transdermal fluorescence detection of the excretion rate of the agent is converted into measured GFR by this system.
LIMITLESS POSSIBILITIES
Shining new light on physiological measurement.
PRODUCT PIPELINE
An extensive portfolio of light-activated agents.

Fluorescence and optical sensor-based systems are being optimized to provide physiological function monitoring at the inpatient and outpatient point of care.
88%
of doctors would like their patients to monitor their health at home, particularly their weight, blood sugar, and vital signs.
- PricewaterhouseCoopers, Health Research Institute Physician Survey, 2010

United States
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 735-0968

Germany
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15

Greater China
Huadong Medicine Co., Ltd
Telephone: 4008-269-985
+86-(0)571-89908581
Zip: 310011
Address: No.866. Moganshan Road, Hangzhou, Zhejiang Province, China
Email: info@eastchinapharm.com

Science How it Works R&D Platform Product Pipeline Patent Estate Preclinical Clinical Focus Areas Nephrology Gastroenterology Ophthalmology Surgery In Discovery Investors Why It's Important Company Overview By the Numbers
Publications MediBeacon Publications Preclinical Publications Industry Literature Company History People Quality Commitment News/Media Contact Get Updates Investors General Questions

*MediBeacon products are in various stages of clinical development and are not yet approved for human use.

**The Transdermal GFR Measurement System (TGFR) is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function. References on this website to measured kidney function and measured renal function refer to the measured GFR.

Terms and Conditions | Privacy Policy | © 2021 MediBeacon All Rights Reserved.

COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.